Literature DB >> 10967795

Lymphedema in women treated for breast cancer.

M M Hull1.   

Abstract

OBJECTIVES: To review the clinical and evidence-based knowledge of lymphedema in women treated for breast cancer, including the anatomy, physiology, pathophysiology, diagnosis, management, and nursing role. DATA SOURCES: Research studies, review articles, clinical literature, American Cancer Society lymphedema work group proceedings.
CONCLUSIONS: Arm lymphedema can be a consequence of treatment for breast cancer and may affect all aspects of quality of life at any time during recovery and long-term survivorship. Prevention and early treatment are vital. IMPLICATIONS FOR NURSING PRACTICE: As patient advocates, nurses can document patient complaints, conduct arm assessments, and reinforce arm precautions at every clinical visit. Knowledge of research and treatment advances is crucial to enhancing the quality of life of women treated for breast cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10967795     DOI: 10.1053/sonc.2000.8117

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  11 in total

1.  SELF-REPORTED MANAGEMENT OF BREAST CANCER-RELATED LYMPHOEDEMA.

Authors:  Elise Radina; Jane Armer; Debbie Daunt; Julie Dusold; Scott Culbertson
Journal:  J Lymphoedema       Date:  2007-10

2.  Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study.

Authors:  Wendy Demark-Wahnefried; Anne Jacobs Kenyon; Pamela Eberle; Ann Skye; William E Kraus
Journal:  Clin Exerc Physiol       Date:  2002-02

3.  Benefits of the uncertainty management intervention for African American and White older breast cancer survivors: 20-month outcomes.

Authors:  Karen M Gil; Merle H Mishel; Michael Belyea; Barbara Germino; Laura S Porter; Margaret Clayton
Journal:  Int J Behav Med       Date:  2006

4.  Risk factors for lymphedema after breast cancer treatment.

Authors:  Sandra A Norman; A Russell Localio; Michael J Kallan; Anita L Weber; Heather A Simoes Torpey; Sheryl L Potashnik; Linda T Miller; Kevin R Fox; Angela DeMichele; Lawrence J Solin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

5.  Effects of physical activity on systemic oxidative/DNA status in breast cancer survivors.

Authors:  Barbara Tomasello; Giuseppe Antonio Malfa; Angela Strazzanti; Santi Gangi; Claudia Di Giacomo; Francesco Basile; Marcella Renis
Journal:  Oncol Lett       Date:  2016-11-30       Impact factor: 2.967

6.  Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms.

Authors:  Sandra A Norman; A Russell Localio; Sheryl L Potashnik; Heather A Simoes Torpey; Michael J Kallan; Anita L Weber; Linda T Miller; Angela Demichele; Lawrence J Solin
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

7.  The epidemiology of arm and hand swelling in premenopausal breast cancer survivors.

Authors:  Electra D Paskett; Michelle J Naughton; Thomas P McCoy; L Douglas Case; Jill M Abbott
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-04       Impact factor: 4.254

Review 8.  Does Exercise Have a Preventive Effect on Secondary Lymphedema in Breast Cancer Patients Following Local Treatment? - A Systematic Review.

Authors:  Freerk T Baumann; Alexandra Reike; Michael Hallek; Joachim Wiskemann; Vanessa Reimer
Journal:  Breast Care (Basel)       Date:  2018-05-03       Impact factor: 2.860

Review 9.  Inflammatory Manifestations of Lymphedema.

Authors:  Catherine L Ly; Raghu P Kataru; Babak J Mehrara
Journal:  Int J Mol Sci       Date:  2017-01-17       Impact factor: 5.923

10.  An infrared 3D scanning device as a novel limb volume measurement tool in breast cancer patients.

Authors:  Bernadette N White; Iris M Lu; LeslieAnn S Kao; J Brandon Dixon; Michael J Weiler; Nathan D Frank; Jill Binkley; Preeti Subhedar; Joel Okoli; Karen Buhariwalla; Adriana Suarez-Ligon; Sheryl G A Gabram-Mendola
Journal:  World J Surg Oncol       Date:  2020-10-27       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.